Only five patients with acute infection had NT-proBNP levels higher than the cut-off value to predict the adverse outcome of severe COVID-19 (Figure S1), which was previously determined to be 88.64  pg/mL [20]. The gene discussed is NPPB; the disease is COVID-19.